C57BL/6NTac-Xbp1tm1a(EUCOMM)Wtsi/IcsOrl

Status

Available to order

EMMA IDEM:07516
International strain nameC57BL/6NTac-Xbp1tm1a(EUCOMM)Wtsi/IcsOrl
Alternative nameEPD0038_2_E10
Strain typeTargeted Mutant Strains
Allele/Transgene symbolXbp1tm1a(EUCOMM)Wtsi
Gene/Transgene symbolXbp1
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider ICS, Institut Clinique de la Souris
Provider affiliationICS, Institut Clinique de la Souris
Genetic informationThis mouse line originates from EUCOMM ES clone EPD0038_2_E10. For further details on the construction of this clone see the page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France
Animals used for archivingheterozygous C57BL/6NTac, wild-type C57BL/6NTac
Stage of embryos8-cell

Disease and phenotype information

IMPC phenotypes (allele matching)
  • increased body weight / IMPC
  • abnormal lens morphology / IMPC
  • cataract / IMPC
  • abnormal urination / IMPC
  • decreased circulating triglyceride level / IMPC
  • abnormal bone mineralization / IMPC
  • thrombocytopenia / IMPC
  • increased lean body mass / IMPC
  • abnormal vertebral arch morphology / IMPC
  • vertebral fusion / IMPC
  • abnormal behavior / IMPC
  • decreased T cell number / IMPC
  • decreased circulating cholesterol level / IMPC
  • increased total body fat amount / IMPC
  • increased grip strength / IMPC
  • increased bone mineral content / IMPC
  • preweaning lethality, complete penetrance / IMPC
IMPC phenotypes (gene matching)
  • decreased circulating triglyceride level / IMPC
  • abnormal behavior / IMPC
  • decreased T cell number / IMPC
  • thrombocytopenia / IMPC
  • increased grip strength / IMPC
  • increased mean corpuscular volume / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • increased total body fat amount / IMPC
  • increased mean corpuscular hemoglobin / IMPC
  • persistence of hyaloid vascular system / IMPC
  • decreased leukocyte cell number / IMPC
  • cataract / IMPC
  • decreased large unstained cell number / IMPC
  • decreased red blood cell distribution width / IMPC
  • decreased circulating cholesterol level / IMPC
  • increased lean body mass / IMPC
  • abnormal lens morphology / IMPC
  • vertebral fusion / IMPC
  • decreased lymphocyte cell number / IMPC
  • increased bone mineral content / IMPC
  • abnormal bone mineralization / IMPC
  • increased body weight / IMPC
  • abnormal vertebral arch morphology / IMPC
  • abnormal urination / IMPC
MGI phenotypes (gene matching)
  • abnormal heart development / MGI
  • thin ventricular wall / MGI
  • enlarged pericardium / MGI
  • absent trabeculae carneae / MGI
  • decreased cell proliferation / MGI
  • abnormal liver development / MGI
  • liver hypoplasia / MGI
  • small liver / MGI
  • wavy neural tube / MGI
  • anemia / MGI
  • impaired hematopoiesis / MGI
  • abnormal blood vessel morphology / MGI
  • decreased embryo size / MGI
  • anoxia / MGI
  • pallor / MGI
  • increased hepatocyte apoptosis / MGI
  • embryonic growth retardation / MGI
  • decreased hepatocyte proliferation / MGI
  • abnormal extraembryonic tissue physiology / MGI
  • myocardial necrosis / MGI
  • decreased embryo weight / MGI
  • embryonic lethality during organogenesis, complete penetrance / MGI
  • embryo tissue necrosis / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).